Vetoquinol Financial Statements From 2010 to 2024
| VETO Stock | EUR 99.00 1.40 1.43% |
Check Vetoquinol financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Vetoquinol main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . Vetoquinol financial statements analysis is a perfect complement when working with Vetoquinol Valuation or Volatility modules.
Vetoquinol |
Vetoquinol Company Return On Equity Analysis
Vetoquinol's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Vetoquinol Return On Equity | 0.11 |
Most of Vetoquinol's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Vetoquinol is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Vetoquinol has a Return On Equity of 0.11. This is 100.46% lower than that of the Pharmaceuticals sector and 94.88% lower than that of the Health Care industry. The return on equity for all France stocks is 135.48% lower than that of the firm.
Vetoquinol Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Vetoquinol's current stock value. Our valuation model uses many indicators to compare Vetoquinol value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Vetoquinol competition to find correlations between indicators driving Vetoquinol's intrinsic value. More Info.Vetoquinol is rated first in return on equity category among related companies. It is rated first in return on asset category among related companies reporting about 0.70 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Vetoquinol is roughly 1.42 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Vetoquinol by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Vetoquinol's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Vetoquinol's earnings, one of the primary drivers of an investment's value.About Vetoquinol Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Vetoquinol income statement, its balance sheet, and the statement of cash flows. Vetoquinol investors use historical funamental indicators, such as Vetoquinol's revenue or net income, to determine how well the company is positioned to perform in the future. Although Vetoquinol investors may use each financial statement separately, they are all related. The changes in Vetoquinol's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Vetoquinol's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Vetoquinol Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Vetoquinol. Please read more on our technical analysis and fundamental analysis pages.
Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. Vetoquinol SA was founded in 1933 and is headquartered in Lure, France. Vetoquinol operates under Drug Manufacturers - Major classification in France and is traded on Paris Stock Exchange. It employs 2004 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out the analysis of Vetoquinol Correlation against competitors. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Complementary Tools for Vetoquinol Stock analysis
When running Vetoquinol's price analysis, check to measure Vetoquinol's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vetoquinol is operating at the current time. Most of Vetoquinol's value examination focuses on studying past and present price action to predict the probability of Vetoquinol's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vetoquinol's price. Additionally, you may evaluate how the addition of Vetoquinol to your portfolios can decrease your overall portfolio volatility.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |